Skip to content
akaturk Academic measurement
Sign in Register

Academician

ÇİĞDEM GÜNGÖRMEZ

DOKTOR ÖĞRETİM ÜYESİ

SİİRT ÜNİVERSİTESİ TIP FAKÜLTESİ TEMEL TIP BİLİMLERİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Tıbbi Biyoloji

A quick look at recorded outputs — details below.

  • Articles 11
  • Projects 0
  • Books 2
  • Proceedings 18
  • Patents 0
  • Artistic 0
Scopus (SJR) Q1 0 Q2 6 Q3 0 Q4 3
WoS (JCR) Q1 0 Q2 2 Q3 2 Q4 5
TR Index 4 articles

Field+year+type normalized OpenAlex percentiles — not Clarivate ESI / SciVal.

Top 1% articles 0
Top 10% articles 0
Avg percentile 50.5%
Top 1% share 0.0%
Top 10% share 0.0%

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

Index filters

11 publications total

Scopus (SJR)
Q1 0 Q2 6 Q3 0 Q4 3
WoS (JCR)
Q1 0 Q2 2 Q3 2 Q4 5
TR Index
4 articles

Article list

  1. 2025 Prophylactic Olive Leaf Tea as a Nutraceutical Strategy: Tumor Suppression and Systemic Protection Current Issues in Molecular Biology DOI 10.3390/cimb47110926 YÖKSİS SJR Q2 JCR Q2 OpenAlex 67.6%
  2. 2025 Quercetin-Mediated Modulation of Tumor Suppressor miR-15a, miR-34a, and p53 Signaling in MCF-7 Breast Cancer Cells Commagene Journal of Biology DOI 10.31594/commagene.1662649 YÖKSİS TR Index SJR Q4 OpenAlex 7.3%
  3. 2024 Identification of hub genes and key pathways targeted by miRNAs in pancreatic ductal adenocarcinoma: MAPK3/8/9 and TGFBR1/2 Human Gene DOI 10.1016/j.humgen.2024.201267 YÖKSİS SJR Q4 JCR Q4 OpenAlex 47.4%
  4. 2022 miRNA Profile and Bioinformatic Analysis for Diagnosis in Patients with Stage IIIA Colon Cancer Biochemical Genetics DOI 10.1007/S10528-021-10096-1 YÖKSİS SJR Q2 JCR Q3 OpenAlex 49.0%
  5. 2021 Immune Plasma Therapy in COVID-19 Infection: The experience of Siirt Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi DOI 10.5505/deutfd.2021.90277 YÖKSİS OpenAlex 9.6%
  6. 2019 Novel miRNAs as potential biomarkers in stage II colon cancer: microarray analysis Molecular Biology Reports DOI 10.1007/s11033-019-04868-7 YÖKSİS SJR Q2 JCR Q4 OpenAlex 89.7%
  7. 2018 MIR-378 TARGET GENE TGFB2 IN THE STAGE II COLON CANCER TISSUE International Journal of Advanced Research (IJAR) DOI 10.21474/IJAR01/7324 YÖKSİS OpenAlex 4.8%
  8. 2025 Prophylactic Olive Leaf Tea as a Nutraceutical Strategy: Tumor Suppression and Systemic Protection CURRENT ISSUES IN MOLECULAR BIOLOGY DOI 10.3390/cimb47110926 YÖKSİS SJR Q2 JCR Q2 OpenAlex 67.5%
  9. 2022 miRNA Profile and Bioinformatic Analysis for Diagnosis in Patients with Stage IIIA Colon Cancer BIOCHEMICAL GENETICS DOI 10.1007/s10528-021-10096-1 YÖKSİS SJR Q2 JCR Q3 OpenAlex 49.0%
  10. 2021 Anti-Cytokine Treatment in COVID-19 Disease: Tocilizumab J Basic Clin Health Sci DOI 10.30621/jbachs.902996 YÖKSİS TR Index JCR Q4 OpenAlex 74.1%
  11. 2019 IDENTIFICATION OF MIR-145-1, MIR-21-2 AND MIR-92-1EXPRESSION AND TARGET GENES IN COLON CANCER STAGE IIIAPATIENTS Turkish Journal of Biochemistry-Turk Biyokimya Dergisi YÖKSİS SJR Q4 JCR Q4
  12. 2019 Novel miRNAs as potential biomarkers in stage II colon cancer: microarray analysis MOLECULAR BIOLOGY REPORTS DOI 10.1007/s11033-019-04868-7 YÖKSİS SJR Q2 JCR Q4 OpenAlex 89.7%
  13. 2017 Expression of miR-143, miR-145, miR-192, Tumor Suppressor miRNAs usingqPCR in Colon Cancer stage II Harran Üniversitesi Tıp Fakültesi Dergisi YÖKSİS TR Index
  14. 2017 Stage II Kolon kanseri dokularında Onkogenik microRNA olan miR-92, miR21,miR-155’in qRT-PCR’da Ekspresyonu Harran Üniversitesi Tıp Fakültesi Dergisi YÖKSİS TR Index

Back to academicians